Skip to Main Content

INFORMATION FOR

Harvey Risch, MD, PhD

Professor Emeritus and Senior Research Scientist in Epidemiology (Chronic Diseases); Affiliated Faculty, Yale Institute for Global Health

Contact Information

Harvey Risch, MD, PhD

Mailing Address

  • Chronic Disease Epidemiology

    PO Box 208034, 60 College Street

    New Haven, CT 06520-8034

    United States

Research Summary

Dr. Risch's research interests are in the areas of cancer etiology and prevention, and in epidemiology methods. He is especially interested in the effects of reproductive factors, diet, genetic predisposition, and histopathologic factors in the causation of ovarian cancer, and these factors as well as infection and immune functioning in the etiology of pancreatic cancer. His major research projects have included studies of ovarian cancer, pancreas cancer, lung cancer, bladder cancer, esophageal and stomach cancer, and of cancers related to usage of oral contraceptives and noncontraceptive estrogens. Dr. Risch is Associate Editor of the Journal of the National Cancer Institute, Editor of the International Journal of Cancer, and has been a Member of the Board of Editors, the American Journal of Epidemiology.

Coauthors

Research Interests

Esophageal Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Polymorphism, Genetic; Gonadal Steroid Hormones; Stomach Neoplasms; Helicobacter pylori; Molecular Epidemiology; Germ-Line Mutation; Host-Pathogen Interactions

Public Health Interests

Cancer; Epidemiology Methods; Genetics, Genomics, Epigenetics; Infectious Diseases; Maternal & Child Health; Nutrition; Pharmaceuticals and Medical Devices; Pharmacoepidemiology; COVID-19

Selected Publications

  • Dietary omega-3 fatty acids and endometrial cancer risk in the Epidemiology of Endometrial Cancer Consortium: An individual-participant meta-analysisBrasky T, Hade E, Cohn D, Newton A, Petruzella S, O'Connell K, Bertrand K, Cook L, De Vivo I, Du M, Freudenheim J, Friedenreich C, Goodman M, Gorzelitz J, Ibiebele T, Krogh V, Liao L, Lipworth L, Lu L, McCann S, O'Mara T, Palmer J, Ponte J, Prizment A, Risch H, Sandin S, Schouten L, Setiawan V, Shu X, Trabert B, van den Brandt P, Webb P, Wentzensen N, Wilkens L, Wolk A, Yu H, Neuhouser M. Dietary omega-3 fatty acids and endometrial cancer risk in the Epidemiology of Endometrial Cancer Consortium: An individual-participant meta-analysis Gynecologic Oncology 2022 DOI: 10.1016/j.ygyno.2022.10.015.
  • Abstract IA-11: An exception to the rule: A coding functional variant at a pancreatic cancer GWAS locusJermusyk A, Zhong J, Gordon N, Connelly K, Perera S, Abdolalizadeh E, Zhang T, O'Brien A, Hoskins J, Collins I, Eiser D, Yuan C, Risch H, Jacobs E, Li D, Du M, Stolzenberg-Solomon R, Klein A, Smith J, Wolpin B, Chanock S, Shi J, Petersen G, Westlake C, Amundadottir L. Abstract IA-11: An exception to the rule: A coding functional variant at a pancreatic cancer GWAS locus Cancer Research 2020, 80: ia-11-ia-11. DOI: 10.1158/1538-7445.panca20-ia-11.
  • Abstract 1200: Associations between genetically predicted blood protein biomarkers and pancreatic ductal adenocarcinoma riskZhu J, Shu X, Guo X, Liu D, bao J, Milne R, Giles G, Wu C, Du M, White E, Risch H, Malats N, Duell E, Goodman P, Li D, Bracci P, Katzke V, Neale R, Gallinger S, Eeden S, Arslan A, Canzian F, Kooperberg C, Wolpin B, Beane-Freeman L, Scelo G, Visvanatha K, Haiman C, Marchand L, Yu H, Petersen G, Stolzenberg-Solomon R, Klein A, Amundadottir L, Cai Q, Long J, Shu X, Zheng W, Wu L. Abstract 1200: Associations between genetically predicted blood protein biomarkers and pancreatic ductal adenocarcinoma risk Cancer Research 2020, 80: 1200-1200. DOI: 10.1158/1538-7445.am2020-1200.
  • Abstract 1213: Genome-wide interaction scan identifies gene by smoking interaction at 2q21.3 for pancreatic cancer riskKundu P, Mocci E, Wheeler W, Amundadottir L, Li D, Jacobs E, Petersen G, Wolpin B, Risch H, Kraft P, Chatterjee N, Klein A, Stolzenberg-Solomon R. Abstract 1213: Genome-wide interaction scan identifies gene by smoking interaction at 2q21.3 for pancreatic cancer risk Cancer Research 2020, 80: 1213-1213. DOI: 10.1158/1538-7445.am2020-1213.
  • Abstract 3498: Ovarian cancer risk factors multiply to create high risk in pre-menopausal womenPhung M, Mukherjee B, Lee A, Webb P, Risch H, Doherty J, Harris H, Goodman M, Ness R, Modugno F, Jensen A, Kjaer S, Terry K, Cramer D, Ziogas A, Anton-Culver H, Pike M, Wu A, Pearce C. Abstract 3498: Ovarian cancer risk factors multiply to create high risk in pre-menopausal women Cancer Research 2020, 80: 3498-3498. DOI: 10.1158/1538-7445.am2020-3498.
  • Abstract B32: Are ovarian cancer risk factors different for women with endometriosis?Muthukumar A, Khoja L, Webb P, Risch H, Doherty J, Harris H, Goodman M, Ness R, Modugno F, Kjaer S, Jensen A, Schildkraut J, Berchuck A, Terry K, Cramer D, Titus L, Anton-Culver H, Ziogas A, Wu A, Pike M, Pearce C, Lee A. Abstract B32: Are ovarian cancer risk factors different for women with endometriosis? Clinical Cancer Research 2020, 26: b32-b32. DOI: 10.1158/1557-3265.ovca19-b32.
  • Hepcidin-regulating Iron-metabolism Genes and Pancreatic Ductal Adenocarcinoma: A Pathway Analysis of Genome-wide Association StudiesJulián-Serrano S, Yuan F, Benyamin B, Wheeler W, Amundadottir L, Jacobs E, Kraft P, Li D, Petersen G, Risch H, Wolpin B, Yu K, Klein A, Stolzenberg-Solomon R. Hepcidin-regulating Iron-metabolism Genes and Pancreatic Ductal Adenocarcinoma: A Pathway Analysis of Genome-wide Association Studies Cancer Epidemiology Biomarkers & Prevention 2020, 29: 692-692. DOI: 10.1158/1055-9965.epi-20-0056.
  • Abstract 640: Breastfeeding pattern and ovarian cancer risk: Results from the Ovarian Cancer Association ConsortiumSasamoto N, Babic A, Jordan S, Risch H, Harris H, Rossing M, Doherty J, Goodman M, Thompson P, Kjær S, Jensen A, Schildkraut J, Titus L, Cramer D, Bandera E, Sieh W, McGuire V, Sutphen R, Pearce C, Wu A, Pike M, Webb P, Modugno F, Terry K. Abstract 640: Breastfeeding pattern and ovarian cancer risk: Results from the Ovarian Cancer Association Consortium 2019, 640-640. DOI: 10.1158/1538-7445.sabcs18-640.
  • A Pathway Analysis of Hereditary Hemochromatosis-related Genes and Pancreatic Ductal Adenocarcinoma Risk (FS11-05-19)Julián-Serrano S, Yu K, Yuan F, Wheeler W, Karimi P, Amundadottir L, Jacobs E, Kraft P, Li D, Petersen G, Risch H, Wolphin B, Klein A, Stolzenberg-Solomon R. A Pathway Analysis of Hereditary Hemochromatosis-related Genes and Pancreatic Ductal Adenocarcinoma Risk (FS11-05-19) Current Developments In Nutrition 2019, 3 PMCID: PMC6573995, DOI: 10.1093/cdn/nzz037.fs11-05-19.
  • Mo1372 – Genetic Susceptibility to Chronic Inflammatory Intestinal Diseases and Pancreatic Ductual Adenocarcinoma: A Pathway Analysis of Genome-Wide Association StudiesYuan F, Hung R, Zhang H, Wheeler W, Platz E, Amundadottir L, Jacobs E, Kraft P, Li D, Petersen G, Risch H, Wolpin B, Yu K, Klein A, Stolzenberg-Solomo R. Mo1372 – Genetic Susceptibility to Chronic Inflammatory Intestinal Diseases and Pancreatic Ductual Adenocarcinoma: A Pathway Analysis of Genome-Wide Association Studies Gastroenterology 2019, 156: s-755-s-756. DOI: 10.1016/s0016-5085(19)38824-9.
  • Abstract 242: Large pathway and gene set analysis of GWAS data identifies novel associations for pancreatic cancerWalsh N, Zhang H, Hyland P, Yang Q, Mocci E, Zhang M, Childs E, Wang Z, Chanock S, Hartge P, Hoover R, Kraft P, Li D, Jacobs E, Petersen G, Wolpin B, Risch H, Amundadottir L, Yu K, Klein A, Stolzenberg-Solomon R. Abstract 242: Large pathway and gene set analysis of GWAS data identifies novel associations for pancreatic cancer Cancer Research 2018, 78: 242-242. DOI: 10.1158/1538-7445.am2018-242.
  • Abstract 1326: A pooled genome-wide association study of pancreatic cancer susceptibility loci in American JewsStreicher S, Klein A, Olson S, Kurtz R, DeWan A, Zhao H, Risch H. Abstract 1326: A pooled genome-wide association study of pancreatic cancer susceptibility loci in American Jews Cancer Research 2017, 77: 1326-1326. DOI: 10.1158/1538-7445.am2017-1326.
  • Abstract 1295: Genomewide gene-diabetes and gene-obesity interaction scan in 7095 cases and 10710 controls from Pancreatic Cancer Cohort Consortium and Pancreatic Cancer Case Control ConsortiumTang H, Jiang L, Amundadottir L, Risch H, Stolzenberg-Solomon R, Klein A, Wolpin B, Petersen G, Chatterjee N, Li D, Kraft P, Wei P. Abstract 1295: Genomewide gene-diabetes and gene-obesity interaction scan in 7095 cases and 10710 controls from Pancreatic Cancer Cohort Consortium and Pancreatic Cancer Case Control Consortium Cancer Research 2017, 77: 1295-1295. DOI: 10.1158/1538-7445.am2017-1295.
  • Abstract 2293: Oligomenorrhea, polycystic ovary syndrome, and risk of ovarian cancer histotypes, evidence from the Ovarian Cancer Association ConsortiumHarris H, Jordan S, Risch H, Rossing M, Goodman M, Modugno F, Kjær S, Schildkraut J, Bandera E, Wentzensen N, Phelan C, Anton-Culver H, Wu A, Terry K. Abstract 2293: Oligomenorrhea, polycystic ovary syndrome, and risk of ovarian cancer histotypes, evidence from the Ovarian Cancer Association Consortium Cancer Research 2017, 77: 2293-2293. DOI: 10.1158/1538-7445.am2017-2293.
  • Abstract 3297: Survival predictors of Burkitt's lymphoma in children, adults and elderly in the United States during 2000-2013Mukhtar F, Boffetta P, Risch H, Park J, Bubu O, Womack L, Tran T, Zgibor J, Luu H. Abstract 3297: Survival predictors of Burkitt's lymphoma in children, adults and elderly in the United States during 2000-2013 Cancer Research 2017, 77: 3297-3297. DOI: 10.1158/1538-7445.am2017-3297.
  • Abstract A27: Timing of pregnancies and oral contraceptive use and risk of ovarian cancerBodelon C, Risch H, Modugno F, Webb P, Pearce C, Pike M, Wentzensen N. Abstract A27: Timing of pregnancies and oral contraceptive use and risk of ovarian cancer Cancer Epidemiology Biomarkers & Prevention 2017, 26: a27-a27. DOI: 10.1158/1538-7755.carisk16-a27.
  • Chronic Recreational Physical Inactivity and Epithelial Ovarian Cancer RiskCannioto R, LaMonte M, Risch H, Hong C, Sucheston-Campbell L, Eng K, Szender J, Chang-Claude J, Schmalfeldt B, Klapdor R, Gower E, Minlikeeva A, Zirpoli G, Bandera E, Berchuck A, Cramer D, Doherty J, Edwards R, Fridley B, Goode E, Goodman M, Hogdall E, Hosono S, Jensen A, Jordan S, Kjaer S, Matsuo K, Ness R, Olsen C, Olson S, Pearce C, Pike M, Rossing M, Szamreta E, Thompson P, Tseng C, Vierkant R, Webb P, Wentzensen N, Wicklund K, Winham S, Wu A, Modugno F, Schildkraut J, Terry K, Kelemen L, Moysich K. Chronic Recreational Physical Inactivity and Epithelial Ovarian Cancer Risk Obstetrical & Gynecological Survey 2016, 71: 528-530. DOI: 10.1097/ogx.0000000000000357.
  • Association Between Menopausal Estrogen-Only Therapy and Ovarian Carcinoma RiskLee A, Ness R, Roman L, Terry K, Schildkraut J, Chang-Claude J, Doherty J, Menon U, Cramer D, Gayther S, Risch H, Gentry-Maharaj A, Goodman M, Modugno F, Eilber U, Moysich K, Berchuck A, Rossing M, Jensen A, Wicklund K, Cushing-Haugen K, Hogdall E, Rudolph A, Thompson P, Wilkens L, Kjaer S, Carney M, Stram D, Ramus S, Wu A, Pike M, Pearce C. Association Between Menopausal Estrogen-Only Therapy and Ovarian Carcinoma Risk Obstetrical & Gynecological Survey 2016, 71: 470-471. DOI: 10.1097/01.ogx.0000489579.62561.b8.
  • Randomized trial of exercise vs. usual care on cancer biomarkers in ovarian cancer survivors: The Women’s Activity and Lifestyle Study in Connecticut (WALC).Cartmel B, Zhou Y, Gottlieb L, Li F, Ercolano E, Harrigan M, McCorkle R, Ligibel J, Gogoi R, Schwartz P, Risch H, Irwin M. Randomized trial of exercise vs. usual care on cancer biomarkers in ovarian cancer survivors: The Women’s Activity and Lifestyle Study in Connecticut (WALC). Journal Of Clinical Oncology 2016, 34: 5561-5561. DOI: 10.1200/jco.2016.34.15_suppl.5561.
  • Abstract B21: BRCA mutation status is not associated with better long-term survival from epithelial ovarian cancer.Kotsopoulos J, Fan I, McLaughlin J, Rosen B, May T, Risch H, Sun P, Narod S. Abstract B21: BRCA mutation status is not associated with better long-term survival from epithelial ovarian cancer. Clinical Cancer Research 2016, 22: b21-b21. DOI: 10.1158/1557-3265.ovca15-b21.
  • Association between Helicobacter pylori and pancreatic cancer risk: A meta-analysisNeale R, Schulte A, Pandeya N, Fawcett J, Fritschi L, Risch H, Whiteman D. Association between Helicobacter pylori and pancreatic cancer risk: A meta-analysis Pancreatology 2015, 15: s83. DOI: 10.1016/j.pan.2015.05.307.
  • Randomized trial of exercise on quality of life and fatigue in women diagnosed with ovarian cancer: The Women’s Activity and Lifestyle Study in Connecticut (WALC).Zhou Y, Gottlieb L, Cartmel B, Li F, Ercolano E, Harrigan M, McCorkle R, Ligibel J, Von Gruenigen V, Gogoi R, Schwartz P, Risch H, Irwin M. Randomized trial of exercise on quality of life and fatigue in women diagnosed with ovarian cancer: The Women’s Activity and Lifestyle Study in Connecticut (WALC). Journal Of Clinical Oncology 2015, 33: 9505-9505. DOI: 10.1200/jco.2015.33.15_suppl.9505.
  • Abstract 2167: Infertility and risk of incident endometrial carcinoma: a pooled analysis from the Epidemiology of Endometrial Cancer ConsortiumYang H, Cook L, Weiderpass E, Adami H, Anderson K, Cai H, Cerhan J, Clendenen T, Felix A, Friedenreich C, Garcia-Closas M, Goodman M, Liang X, Lissowska J, Lu L, Magliocco A, McCann S, Moysich K, Olson S, Pike M, Polidoro S, Ricceri F, Risch H, Sacerdote C, Setiawan V, Shu X, Spurdle A, Trabert B, Webb P, Wentzensen N, Xiang Y, Xu Y, Yu H, Zeleniuch-Jacquotte A, Brinton L. Abstract 2167: Infertility and risk of incident endometrial carcinoma: a pooled analysis from the Epidemiology of Endometrial Cancer Consortium 2014, 2167-2167. DOI: 10.1158/1538-7445.am2014-2167.
  • Abstract 2214: Genome-wide gene-diabetes and gene-obesity interaction scan in the pancreatic cancer case control consortiumTang H, Duell E, Risch H, Olson S, Bueno-de-Mesquita H, Gallinger S, Holly E, Petersen G, Bracci P, McWilliams R, Jenab M, Riboli E, Tjønneland A, Boutron-Ruault M, Kaaks R, Trichopoulos D, Panico S, Sund M, Peeters P, Khaw K, Amos C, Li D, Wei P. Abstract 2214: Genome-wide gene-diabetes and gene-obesity interaction scan in the pancreatic cancer case control consortium 2014, 2214-2214. DOI: 10.1158/1538-7445.am2014-2214.
  • Abstract 4809: Dietary fat intake and risk of pancreatic cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.Arem H, Mayne S, Sampson J, Risch H, Stolzenberg-Solomon R. Abstract 4809: Dietary fat intake and risk of pancreatic cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Cancer Research 2013, 73: 4809-4809. DOI: 10.1158/1538-7445.am2013-4809.
  • Abstract 14: Body mass index and type 2 diabetes genetic risk scores and endometrial cancer risk among women of European ancestry.Prescott J, Setiawan V, Wentzensen N, Schumacher F, Yu H, Delahanty R, Chanock S, Chen C, Garcia-Closas M, Haiman C, Hartge P, Horn-Ross P, Le Marchand L, Lissowska J, Lu L, Risch H, Shu X, Ursin G, Weiss N, Yang H, Kraft P, De Vivo I. Abstract 14: Body mass index and type 2 diabetes genetic risk scores and endometrial cancer risk among women of European ancestry. Cancer Epidemiology Biomarkers & Prevention 2012, 21: 14-14. DOI: 10.1158/1055-9965.gwas-14.
  • Abstract 61: Genetic pathways related to vitamin D and risk of pancreatic cancer.Arem H, Maeder D, Yu K, Wheeler B, Steplowski E, Freedman N, Mayne S, Risch H, Sampson J, Stolzenberg-Solomon R. Abstract 61: Genetic pathways related to vitamin D and risk of pancreatic cancer. Cancer Epidemiology Biomarkers & Prevention 2012, 21: 61-61. DOI: 10.1158/1055-9965.gwas-61.
  • Trial of exercise in ovarian cancer survivors.Irwin M, Gottlieb L, Cartmel B, Ercolano E, Rothbard M, Zhou Y, Schwartz P, Ligibel J, Von Gruenigen V, Risch H. Trial of exercise in ovarian cancer survivors. Journal Of Clinical Oncology 2012, 30: tps1614-tps1614. DOI: 10.1200/jco.2012.30.15_suppl.tps1614.
  • Abstract 633: Synergistic interplay between long-term overweight and long menstrual years in endometrial cancerLu L, Lee S, Mayne S, Irwin M, Cartmel B, Risch H, Yu H. Abstract 633: Synergistic interplay between long-term overweight and long menstrual years in endometrial cancer Cancer Research 2012, 72: 633-633. DOI: 10.1158/1538-7445.am2012-633.
  • Abstract 3655: Stem cell-associated gene Lin-28B genotype and phenotype in epithelial ovarian cancer and their associations with disease survival outcomesLu L, Katsaros D, Risch H, Yu H. Abstract 3655: Stem cell-associated gene Lin-28B genotype and phenotype in epithelial ovarian cancer and their associations with disease survival outcomes Cancer Research 2012, 72: 3655-3655. DOI: 10.1158/1538-7445.am2012-3655.
  • Abstract 625: Flavonoid intake and risk of pancreatic cancer in the National Institutes of Health-AARP Diet and Health Study CohortArem H, Bobe G, Sampson J, Subar A, Park Y, Risch H, Hollenbeck A, Mayne S, Stolzenberg-Solomon R. Abstract 625: Flavonoid intake and risk of pancreatic cancer in the National Institutes of Health-AARP Diet and Health Study Cohort Cancer Research 2012, 72: 625-625. DOI: 10.1158/1538-7445.am2012-625.
  • Abstract 1029: The association of body mass index with risk of endometrial cancer subtypes: Pooled analysis in E2C2Setiawan V, Yang H, Pike M, McCann S, Yu H, Xiang Y, Wolk A, Wentzensen N, Weiss N, Webb P, van den Brandt P, van de Vijver K, Thompson P, Strom B, Spurdle A, Shu X, Schairer C, Sacerdote C, Rohan T, Robien K, Risch H, Ricceri F, Rebbeck T, Rastogi R, Prescott J, Polidoro S, Park Y, Olson S, Moysich K, Miller A, McCullough M, Matsuno R, Magliocco A, Lurie G, Lu L, Lissowska J, Liang X, Lacey J, Kolonel L, Henderson B, Hankinson S, Håkansson N, Goodman M, Gaudet M, Garcia-Closas M, Friedenreich C, Freudenheim J, Doherty J. Abstract 1029: The association of body mass index with risk of endometrial cancer subtypes: Pooled analysis in E2C2 Cancer Research 2012, 72: 1029-1029. DOI: 10.1158/1538-7445.am2012-1029.
  • Abstract 1649: Genome-wide association study of copy number variations in serous epithelial ovarian cancer susceptibilityTsai Y, Monteiro A, Phelan C, Iversen E, Fridley B, Chen Y, Chen Z, Permuth-Wey J, Jim H, Vierkant R, Cunningham J, Barnholtz-Sloan J, August A, Sutphen R, Narod S, Risch H, Schildkraut J, Goode E, Fenstermacher D, Sellers T. Abstract 1649: Genome-wide association study of copy number variations in serous epithelial ovarian cancer susceptibility Cancer Research 2012, 72: 1649-1649. DOI: 10.1158/1538-7445.am2012-1649.
  • Abstract 1678: European ancestry and ovarian cancer: Testing for their association using case control dataRaska P, Iversen E, Chen A, Chen Z, Fridley B, Permuth-Wey J, Tsai Y, Vierkant R, Goode E, Risch H, Schildkraut J, Sellers T, Barnholtz-Sloan J. Abstract 1678: European ancestry and ovarian cancer: Testing for their association using case control data Cancer Research 2012, 72: 1678-1678. DOI: 10.1158/1538-7445.am2012-1678.
  • Abstract 2927: MicroRNA binding site polymorphisms influence ovarian cancer risk in the collaborative oncological gene-environment studyPermuth-Wey J, Lin H, Tsai Y, Zhihua C, Chen Y, Barnholtz-Sloan J, Birrer M, Chanock S, Cramer D, Cunningham J, Fenstermacher D, Fridley B, Garcia-Closas M, Gayther S, Gentry-Maharaj A, Gonzalez-Bosquet J, Iversen E, Jim H, McLaughlin J, Menon U, Monteiro A, Narod S, Phelan C, Ramus S, Risch H, Song H, Sutphen R, Terry K, Tyrer J, Vierkant R, Wentzensen N, Lancaster J, Cheng J, Berchuk A, Pharoah P, Schildkraut J, Goode E, Sellers T. Abstract 2927: MicroRNA binding site polymorphisms influence ovarian cancer risk in the collaborative oncological gene-environment study Cancer Research 2012, 72: 2927-2927. DOI: 10.1158/1538-7445.am2012-2927.
  • Association of KRAS SNP rs61764370 with risk of invasive epithelial ovarian cancer: Implications for clinical testingBerchuck A, Pharoah P, Ramus S, Gayther S, Palmieri R, Pearce C, Couch F, Antonio A, Goode E, Schildkraut J, Chenevix-Trench G, Sellers T, Risch H, Consortium F. Association of KRAS SNP rs61764370 with risk of invasive epithelial ovarian cancer: Implications for clinical testing Gynecologic Oncology 2011, 121: s2-s3. DOI: 10.1016/j.ygyno.2011.02.028.
  • Abstract 4668: Genetic effects and modifiers of radiotherapy and chemotherapy on survival in pancreatic cancerZeng H, Yu H, Lu L, Jain D, Kidd M, Saif M, Chanock S, Hartge P, Risch H. Abstract 4668: Genetic effects and modifiers of radiotherapy and chemotherapy on survival in pancreatic cancer Cancer Research 2011, 71: 4668-4668. DOI: 10.1158/1538-7445.am2011-4668.
  • Abstract 4729: Pathway and gene set analyses for epithelial ovarian cancer (EOC) genome-wide association study (GWAS)Chen Y, Chen Z, Tsai Y, Qu X, Iversen E, Barnholtz-Sloan J, Fridley B, Permuth-Wey J, Risch H, Cunningham J, Vierkant R, Fenstermacher D, Sutphen R, Phelan C, Monteiro A, Birrer M, Cramer D, Narod S, McLaughlin J, Schildkraut J, Goode E, Sellers T. Abstract 4729: Pathway and gene set analyses for epithelial ovarian cancer (EOC) genome-wide association study (GWAS) Cancer Research 2011, 71: 4729-4729. DOI: 10.1158/1538-7445.am2011-4729.
  • Abstract B70: Physical activity and BMI in a population-based case-control study of endometrial cancer riskArem H, Irwin M, Zhou Y, Lu L, Risch H, Yu H. Abstract B70: Physical activity and BMI in a population-based case-control study of endometrial cancer risk Cancer Prevention Research 2010, 3: b70-b70. DOI: 10.1158/1940-6207.prev-10-b70.
  • Abstract ED02-03: Gene, environment, and risk factor interaction in pancreatic cancerRisch H. Abstract ED02-03: Gene, environment, and risk factor interaction in pancreatic cancer Cancer Prevention Research 2010, 3: ed02-03-ed02-03. DOI: 10.1158/1940-6207.prev-10-ed02-03.
  • T2009 Assessment of Novel Genetic Polymorphisms and Risk of Upper Gastrointestinal CarcinomaNg M, Rabkin C, Lochhead P, Lissowska J, Vaughan T, Gammon M, Risch H, Chow W, Hold G, El-Omar E. T2009 Assessment of Novel Genetic Polymorphisms and Risk of Upper Gastrointestinal Carcinoma Gastroenterology 2010, 138: s-612. DOI: 10.1016/s0016-5085(10)62822-3.
  • Abstract 2835: Mitochondrial genetic variants influence ovarian cancer riskPermuth-Wey J, Tsai Y, Chen Y, Chen Z, Lancaster J, Iverson E, Risch H, Barnholtz-Sloan J, Cunningham J, Vierkant R, Fridley B, Fenstermacher D, Sutphen R, Narod S, Goode E, Schildkraut J, Sellers T, Phelan C. Abstract 2835: Mitochondrial genetic variants influence ovarian cancer risk Cancer Research 2010, 70: 2835-2835. DOI: 10.1158/1538-7445.am10-2835.
  • Abstract 4724: A novel region on 8q24.21 is associated with ovarian cancer susceptibilityTsai Y, Chen Y, Chen Z, Permuth-Wey J, Iversen E, Risch H, Barnholtz-Sloan J, Cunningham J, Vierkant R, Fridley B, Fenstermacher D, Sutphen R, Phelan C, Narod S, Schildkraut J, Goode E, Sellers T. Abstract 4724: A novel region on 8q24.21 is associated with ovarian cancer susceptibility Cancer Research 2010, 70: 4724-4724. DOI: 10.1158/1538-7445.am10-4724.
  • OC-052 Assessment of novel genetic polymorphisms and risk of upper gastrointestinal carcinomaHold G, El-Omar E, Chow W, Risch H, Gammon M, Vaughan T, Lissowska J, Lochhead P, Rabkin C, Ng M. OC-052 Assessment of novel genetic polymorphisms and risk of upper gastrointestinal carcinoma Gut 2010, 59: a21. DOI: 10.1136/gut.2009.208959z.
  • MOLECULAR MARKERS AND LONG-TERM PROGNOSIS IN PROSTATE CANCERUchio E, Jain D, Risch H, Li W, Wells C, Concato J. MOLECULAR MARKERS AND LONG-TERM PROGNOSIS IN PROSTATE CANCER Investigative Urology 2009, 181: 813. DOI: 10.1016/s0022-5347(09)62268-0.
  • Erratum: The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensionsAntoniou A, Cunningham A, Peto J, Evans D, Lalloo F, Narod S, Risch H, Eyfjord J, Hopper J, Southey M, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles D, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tryggvadottir L, Syrjakoski K, Kallioniemi O, Eerola H, Nevanlinna H, Pharoah P, Easton D. Erratum: The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions British Journal Of Cancer 2008, 98: 2015-2015. PMCID: PMC2441956, DOI: 10.1038/sj.bjc.6604411.
  • THE QUEENSLAND PANCREATIC CANCER STUDY-IDENTIFYING RISK FACTORS FOR PANCREATIC CANCERNeale R, Whiteman D, Young J, Fritschi L, Fawcete J, Webbl P, Risch H. THE QUEENSLAND PANCREATIC CANCER STUDY-IDENTIFYING RISK FACTORS FOR PANCREATIC CANCER Pancreas 2008, 36: 223. DOI: 10.1097/01.mpa.0000311856.49537.9e.
  • RESPONSE: Re: Carbonated Soft Drink Consumption and Risk of Esophageal AdenocarcinomaMayne S, Risch H, Dubrow R, Chow W, Gammon M, Vaughan T, Fraumeni J. RESPONSE: Re: Carbonated Soft Drink Consumption and Risk of Esophageal Adenocarcinoma Journal Of The National Cancer Institute 2006, 98: 646-647. DOI: 10.1093/jnci/djj171.
  • RESPONSE Re: Etiology of Pancreatic Cancer, With a Hypothesis Concerning the Role of N-Nitroso Compounds and Excess Gastric AcidityRisch H. RESPONSE Re: Etiology of Pancreatic Cancer, With a Hypothesis Concerning the Role of N-Nitroso Compounds and Excess Gastric Acidity Journal Of The National Cancer Institute 2004, 96: 75-76. DOI: 10.1093/jnci/djh019.
  • Epidemiological study of risk factors for gastric carcinoidsLew E, Risch H, Chow W, Gammon M, Vaughan T, Schoenberg J, Stanford J, Farrow D, West A, Rotterdam H, Blot J, Fraumeni J. Epidemiological study of risk factors for gastric carcinoids Gastroenterology 2001, 120: a256. DOI: 10.1016/s0016-5085(08)81265-6.
  • Helicobacter pylori, gastroesophageal reflux, their interrelationships, and the risk of esophageal adenocarcinomaLew E, Risch H, Chow W, Gammon M, Vaughan T, Schoenberg J, Stanford J, West A, Rotterdam H, Blot W, Blaser M, Fraumeni J. Helicobacter pylori, gastroesophageal reflux, their interrelationships, and the risk of esophageal adenocarcinoma Gastroenterology 2001, 120: a31. DOI: 10.1016/s0016-5085(08)80151-5.
  • Helicobacter pylori, gastroesophageal reflux, their interrelationships, and the risk of esophageal adenocarcinomaLEW E, RISCH H, CHOW W, GAMMON M, VAUGHAN T, SCHOENBERG J, STANFORD J, WEST A, ROTTERDAM H, BLOT W. Helicobacter pylori, gastroesophageal reflux, their interrelationships, and the risk of esophageal adenocarcinoma Gastroenterology 2001, 120: a31-a31. DOI: 10.1016/s0016-5085(01)80151-7.
  • Epidemiological study of risk factors for gastric carcinoidsLEW E, RISCH H, CHOW W, GAMMON M, VAUGHAN T, SCHOENBERG J, STANFORD J, FARROW D, WEST A, ROTTERDAM H. Epidemiological study of risk factors for gastric carcinoids Gastroenterology 2001, 120: a256-a256. DOI: 10.1016/s0016-5085(01)81265-8.
  • Pro-inflammatory genotypes of IL-1β, TNF-α and IL-10 increase risk of distal gastric cancer but not of cardia or oesophageal adenocarcinomasEl-Omar E, Chow W, Gammon M, Vaughan T, Risch H, Fraumeni J. Pro-inflammatory genotypes of IL-1β, TNF-α and IL-10 increase risk of distal gastric cancer but not of cardia or oesophageal adenocarcinomas Gastroenterology 2001, 120: a86. DOI: 10.1016/s0016-5085(08)80425-8.
  • Pro-inflammatory genotypes of IL-1β, TNF-α and IL-10 increase risk of distal gastric cancer but not of cardia or oesophageal adenocarcinomasELOMAR E, CHOW W, GAMMON M, VAUGHAN T, RISCH H, FRAUMENIJR J. Pro-inflammatory genotypes of IL-1β, TNF-α and IL-10 increase risk of distal gastric cancer but not of cardia or oesophageal adenocarcinomas Gastroenterology 2001, 120: a86-a86. DOI: 10.1016/s0016-5085(01)80425-x.
  • RESPONSE: Re: Multiple Births and Risk of Epithelial Ovarian CancerWhiteman D, Murphy M, Cook L, Cramer D, Hartge P, Marchbanks P, Nasca P, Ness R, Purdie D, Risch H. RESPONSE: Re: Multiple Births and Risk of Epithelial Ovarian Cancer Journal Of The National Cancer Institute 2001, 93: 319-320. DOI: 10.1093/jnci/93.4.319-a.
  • Etiologic Mechanisms in Epithelial Ovarian CancerRisch H. Etiologic Mechanisms in Epithelial Ovarian Cancer 2001, 307-319. DOI: 10.1007/978-1-4612-2092-3_30.
  • RESPONSE - Re: Hormonal Etiology of Epithelial Ovarian Cancer, With a Hypothesis Concerning the Role of Androgens and ProgesteroneRisch H. RESPONSE - Re: Hormonal Etiology of Epithelial Ovarian Cancer, With a Hypothesis Concerning the Role of Androgens and Progesterone Journal Of The National Cancer Institute 1999, 91: 650a-651. DOI: 10.1093/jnci/91.7.650a.
  • Response - Re: Hormonal Etiology of Epithelial Ovarian Cancer, With a Hypothesis Concerning the Role of Androgens and ProgesteroneRisch H. Response - Re: Hormonal Etiology of Epithelial Ovarian Cancer, With a Hypothesis Concerning the Role of Androgens and Progesterone Journal Of The National Cancer Institute 1999, 91: 650a-651. DOI: 10.1093/jnci/91.7.650-a.
  • ORAL CONTRACEPTIVES AND THE RISK OF OVARIAN CANCERSA N, H R, R M. ORAL CONTRACEPTIVES AND THE RISK OF OVARIAN CANCER Southern Medical Journal 1999, 92: 254. DOI: 10.1097/00007611-199902000-00029.
  • Oral Contraceptives and the Risk of Hereditary Ovarian CancerNarod S, Risch H, Moslehi R, Dorum A, Neuhausen S, Olsson H, Provencher D, Radice P, Bishop S, Brunet J, Ponder B. Oral Contraceptives and the Risk of Hereditary Ovarian Cancer Obstetrical & Gynecological Survey 1999, 54: 33-34.. DOI: 10.1097/00006254-199901000-00018.
  • Hereditary and Familial Ovarian Cancer in Southern OntarioNarod S, Madlensky L, Bradley L, Cole D, Tonin P, Rosen B, Risch H. Hereditary and Familial Ovarian Cancer in Southern Ontario Obstetrical & Gynecological Survey 1995, 50: 194-195.. DOI: 10.1097/00006254-199503000-00017.
  • THE AUTHORS REPLYRisch H, Howe G, Jain M, Burch J, Holowaty E, Miller A. THE AUTHORS REPLY American Journal Of Epidemiology 1994, 140: 187-188. DOI: 10.1093/oxfordjournals.aje.a117231.
  • THE FIRST AUTHOR REPLIESRisch H. THE FIRST AUTHOR REPLIES American Journal Of Epidemiology 1990, 131: 571-573. DOI: 10.1093/oxfordjournals.aje.a115536.
  • Diet and lung cancerMiller A, Risch H. Diet and lung cancer CHEST Journal 1989, 96: 8s-9. DOI: 10.1378/chest.96.1.8s.
  • THE AUTHORS REPLYRisch H. THE AUTHORS REPLY American Journal Of Epidemiology 1989, 129: 862-862. DOI: 10.1093/oxfordjournals.aje.a115203.
  • RE: “POLYCHOTOMOUS LOGISTIC REGRESSION METHODS FOR MATCHED CASE CONTROL STUDIES WITH MULTIPLE CASE OR CONTROL GROUPS”Risch H, Tibshirani R. RE: “POLYCHOTOMOUS LOGISTIC REGRESSION METHODS FOR MATCHED CASE CONTROL STUDIES WITH MULTIPLE CASE OR CONTROL GROUPS” American Journal Of Epidemiology 1988, 128: 446-448. DOI: 10.1093/oxfordjournals.aje.a114991.
  • The Smoke Ring: Tobacco, Money and Multinational PoliticsRisch H. The Smoke Ring: Tobacco, Money and Multinational Politics Journal Of Public Health Policy 1985, 6: 137-140. DOI: 10.2307/3342023.
  • An approximate solution for the standard deterministic epidemic modelRisch H. An approximate solution for the standard deterministic epidemic model Mathematical Biosciences 1983, 63: 1-8. DOI: 10.1016/0025-5564(83)90047-0.